Articles On Polynovo (ASX:PNV)

I wouldn’t typically expect shares in a company with a market capitalisation of $2 billion to rocket over 80% in just a few months. I’m of course talking about medical technology company PolyNovo Ltd (ASX: PNV), a leader in wound care techn...

The onset of COVID-19 has seen ASX biomedical shares become involved in combatting the pandemic. Some companies are focused on treatments and equipment and others on the generation of a vaccine. This has translated to strong share price ap...

At lunch on Monday the S&P/ASX 200 Index (ASX: XJO) looks set to start the shortened week with a disappointing decline. The benchmark index is currently down 0.4% to 6,648.9 points. Here’s what has been happening on the market today: P...

Summary In 2020, the stock market stayed highly volatile due to the negative impact of the coronavirus pandemic.  However, the healthcare sector remained relatively stable and managed to give good returns to the investors. CogState, P...

The healthcare sector has been an interesting one to watch in 2020. Almost all ASX shares have been defined by how they have been affected, and perhaps reacted to, the coronavirus pandemic in 2020. But healthcare, especially so, for obviou...

The S&P/ASX 200 Index (ASX: XJO) has delivered its 5th straight week of gains. While many ASX 200 shares are still well below their pre-COVID-19 price levels, some are not only setting year-to-date highs on the ASX, they’re breaking ou...

In late morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to start the month on a positive note. At the time of writing, the benchmark index is up 0.7% to 6,565.3 points. Four shares that are climbing more than most today are...

The S&P/ASX Healthcare index finished November just 2.72% higher compared to the 9.5% surge in the S&P/ASX 200 Index (ASX: XJO). Sectors that benefitted from lockdowns including technology, ecommerce and consumer staples underperfo...

ShareCafeAustralia…One Hour In…ASX up 33 points ASX200 up 33 points (0.5%) to 6551. AUB (-1.6%); will acquire 360 Underwriting Solutions for $127m. Collins Foods (+4.2%); 1H profit +15%.   Strong result. Domino’s Pizza (+11%); Investor Day...

The PolyNovo Ltd (ASX: PNV) share price has continued its positive run on Monday. In afternoon trade the medical device company’s shares are up over 4% to $3.22. This leaves the PolyNovo share price trading just short of its record high of...

There are around 2,185 stocks on the ASX, but here are just three ASX growth shares I’m really liking at the moment. Objective Corporation Objective Corporation Limited (ASX: OCL) is a multinational software provider with a suite of produc...

The S&P/ASX 200 Index (ASX: XJO) rose by 0.25% to 6,547 points today. Here are some of the highlights from the ASX: SEEK Limited (ASX: SEK) The company released an update about FY21 today at its annual general meeting (AGM). It said...

The Polynovo Ltd (ASX: PNV) share price has lifted higher today on news of an international expansion. Polynovo advised the ASX it was expanding operations into multiple new countries with its ongoing partner, PolyMedics Innovations (PMI)....

Polynovo Ltd (ASX: PNV) shares are on watch today after the company announced expansion in Europe. NovoSorb is a range of bio-resorbable polymers that can be produced in many formats, including film, fibre, foam and coatings. NovoSorb BTM i...

Shares in S&P/ASX 200 (ASX: XJO) company PoloNovo Ltd (ASX: PNV) have rallied in recent months following a string of positive announcements. The last time I wrote about PolyNovo in September, shares were trading around $2.20. In less th...

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) remains suspended following a system upgrade failure at the Australian stock exchange. Prior to the pause, the benchmark index was up a solid 1.2% to 6,484.3 points. Four shares that...

Summary ASX 200-listed PolyNovo Limited receives FDA green light for its BARDA supported pivotal trial IDE. The Company is set to commence a clinical trial at 20 sites to recruit 150 patients. Polynovo estimate recruitment will start e...

The Polynovo Ltd (ASX: PNV) share price is soaring higher today. This comes after the company announced an approval of a pivotal trial investigation device exemption (IDE). During mid-morning trade, shares in the medical device company rea...

In early afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to finish the week on a disappointing note. The benchmark index is currently down 0.5% to 6,386.8 points. Four shares that have not let that hold them back are list...

On Thursday the S&P/ASX 200 Index (ASX: XJO) ran out of steam and ended its impressive winning streak. The benchmark index gave back its morning gains and fell 0.5% to 6,418.2 points. Will the market be able to bounce back from this on...

S&P/ASX 200 Index (ASX: XJO) healthcare shares have surprisingly underperformed other sectors such as energy, consumer staples, financials and technology in October. This likely follows a prior period of outperformance due to COVID-rel...

The PolyNovo Ltd (ASX: PNV) share price shot up 8.73% yesterday after announcing Taiwan FDA approval. PolyNovo is a medical device company specialising in the development of dermal regeneration products. PNV share price Source: Rask Media P...

World Overnight SPI Overnight (Dec) 5942.00 – 103.00 – 1.70% S&P ASX 200 6057.70 + 6.70 0.11% S&P500 3271.03 – 119.65 – 3.53% Nasdaq Comp 11004.87 – 426.48 – 3.73% DJIA 26519.95 – 943.24 – 3.43% S&P500 VIX 40.28 +...

ShareCafeOvernight: Rolling Lockdowns World Overnight SPI Overnight (Dec) 5942.00 – 103.00 – 1.70% S&P ASX 200 6057.70 + 6.70 0.11% S&P500 3271.03 – 119.65 – 3.53% Nasdaq Comp 11004.87 – 426.48 – 3.73% DJIA 26519.95 – 94...

Summary Medical device player PolyNovo Limited has received a green light from Taiwan FDA for the sale of NovoSorb BTM in Taiwan. The Company has also signed a contract with Taiwan-based Evermed to sell its NovoSorb BTM. PolyNovo discl...

28 Oct 2020 - PolyNovo (ASX:PNV) has announced the approval of NovoSorb BTM by the Taiwan FDA for sale in Taiwan.

With populations around the world getting older and chronic disease burden increasing, demand for healthcare services is expected to rise strongly over the coming decades. In light of this, I think the healthcare sector could be a great pl...

On Thursday eligible shareholders of Wesfarmers Ltd (ASX: WES) will be paid the conglomerate’s final dividend. The Bunnings owner is rewarding shareholders with a fully franked 95 cents per share final dividend, which was up almost 22% yea...

PolyNovo Ltd (ASX: PNV) is an exciting name in the health-tech space. As you can see in the chart below, it’s been a volatile ride so far. Here are my thoughts on this up and coming ASX growth share. Source: Rask Media PNV 1-year share pric...

The S&P/ASX 200 Index (ASX: XJO) is back in form at last on Wednesday and is charging notably higher. The benchmark index is currently up 1.8% to 5,888.6 points. Four shares that have climbed more than most today are listed below. Here...

23 Sep 2020 - PolyNovo (ASX:PNV) is excited to announce the appointment of Innova Medical Oy, in Helsinki, to sell NovoSorb® BTM in Finland.

In morning trade on Wednesday the PolyNovo Ltd (ASX: PNV) share price is pushing higher with the market. At the time of writing the medical device company’s shares are up 1.5% to $2.22. This latest gain means the PolyNovo share price is up...

If you have $3,000 to invest in ASX growth shares, then I think the ones listed below would be top options after recent market weakness. Here’s why I would invest $1,000 across each of these growth shares: Kogan.com Ltd (ASX: KGN) The firs...

I continue to believe that the healthcare sector is a great place to invest with a long term view. This is due to favourable industry tailwinds which look set to support demand for healthcare services for a long time to come. While I think...

ASX tech shares have been rocketing in 2020 thanks to the likes of Afterpay Ltd (ASX: APT). The Afterpay share price has surged 144.9% higher but I think the tide is starting to turn. In my mind, biotech shares like Polynovo Ltd (ASX: PNV)...

The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price had a good day on Thursday. Shares in the Aussie pharma group rocketed 9.2% higher to lead the S&P/ASX 200 Index (ASX: XJO) winners. So, what’s causing a surge in Aussie pharm...

I believe that one of the best ways for investors to grow their wealth is to make long term investments in quality shares with strong business models and positive outlooks. Two ASX growth shares that tick a lot of boxes for me right now ar...

It’s been a strong year for many ASX growth shares. Healthcare, gold and tech shares have performed strongly despite the S&P/ASX 200 Index (ASX: XJO) slumping lower. However, it’s hard to know what to buy in the current market. Looking...

The Polynovo Ltd (ASX: PNV) share price has dropped lower in early afternoon trade despite the company announcing it has received a grant from the Victorian Government for its hernia facility. At the time of writing, the Polynovo share pri...

The Mesoblast Limited (ASX: MSB) share price outperformed in August. Shares in the Aussie biotech are up 37.9% in the space of a month after a busy August earnings season.  Why is the Mesoblast share price rocketing higher? August was full...

The A2 Milk Company Ltd (ASX: A2M) share price may be under pressure today following heavy insider selling, but not all executives have been selling shares this week. The Polynovo Ltd (ASX: PNV) share price is storming higher on Friday aft...

The S&P/ASX 200 Index (ASX: XJO) is on course to end the week with a disappointing decline. At the time of writing the benchmark index is down a sizeable 0.9% to 6,072.2 points. Four shares that have not let that hold them back are lis...

World Overnight SPI Overnight (Sep) 6076.00 – 9.00 – 0.15% S&P ASX 200 6126.20 + 9.80 0.16% S&P500 3484.55 + 5.82 0.17% Nasdaq Comp 11625.34 – 39.72 – 0.34% DJIA 28492.27 + 160.35 0.57% S&P500 VIX 24.47 + 1.20 5.16...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AX1)) - Accent Group ((ACF)) - Acrow Formwork And Construction ((ABC)) - AdBri ((AMA)) - Ama Group ((APA)) - APA Group ((AMI)) - Aurelia Metals ((BVS)) - Bravura Solutio...

ShareCafeOvernight: Fly Me To The Moon World Overnight SPI Overnight (Sep) 6095.00 + 15.00 0.25% S&P ASX 200 6116.40 – 45.00 – 0.73% S&P500 3478.73 + 35.11 1.02% Nasdaq Comp 11665.06 + 198.59 1.73% DJIA 28331.92 + 83.48...

World Overnight SPI Overnight (Sep) 6095.00 + 15.00 0.25% S&P ASX 200 6116.40 – 45.00 – 0.73% S&P500 3478.73 + 35.11 1.02% Nasdaq Comp 11665.06 + 198.59 1.73% DJIA 28331.92 + 83.48 0.30% S&P500 VIX 23.27 + 1.24 5.6...

The Polynovo Ltd (ASX: PNV) share price has been among the worst performers on the S&P/ASX 200 Index (ASX: XJO) on Wednesday following the release of its full year results for FY 2020. In afternoon trade the dermal regeneration solutio...

I think that every portfolio should have some exposure to the healthcare industry, including 1 or 2 small-caps that make up less than 5% of the total portfolio’s value. Emerging ASX biotech companies such as Opthea Ltd (ASX: OPT) and Polyn...

The Mesoblast Limited (ASX: MSB) share price could be set to surge after the Aussie biotech company had a huge regulatory breakthrough. What was the big breakthrough? Investors were holding out ahead of the US Oncologic Drugs Adviosry Comm...

Shares in the Aussie biotech company Mesoblast limited (ASX: MSB) continue to fall. In fact, the Mesoblast share price is down 37.0% since Monday’s close to $3.07 per share. It’s not unusual to see big valuation swings in the biotech space...